CRP and major depressive disorder: On the other hand, findings of a recently published randomized clinical trial suggest that the easily available serum CRP levels could serve as a predictive biomarker to screen for MDD patients who might benefit from add-on minocycline to antidepressant treatment (Nettis et al., 2021).